paroxetine has been researched along with Sensitivity and Specificity in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (23.53) | 18.2507 |
| 2000's | 22 (64.71) | 29.6817 |
| 2010's | 4 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajo, E; Olgiati, P; Serretti, A | 1 |
| Ciliberto, M; De Crescenzo, F; Ebmeier, KP; Janiri, L; Menghini, D; Treglia, G | 1 |
| Chen, J; Deng, X; Fang, L; Lei, T; Lei, Y; Qu, Z; Zhang, L; Zhao, X; Zhong, J; Zhou, C; Zou, B | 1 |
| Borman, PJ; Chatfield, MJ; Crowley, EL; Eckers, C; Elder, DP; Francey, SW; Laures, AM; Wolff, JC | 1 |
| Brock, J; Cappelleri, JC; Feltner, DE; Harness, J; Morlock, R; Sambunaris, A | 1 |
| Danhof, M; Della Pasqua, O; Santen, G | 2 |
| Kourti, PV; Samanidou, VF | 1 |
| Hotha, KK; Jagadeesh, B; Jaya Veera, KN; Ravindranath, LK; Venkateswarulu, V; Vijaya Bharathi, D | 1 |
| Fauler, G; Leis, HJ; Windischhofer, W | 1 |
| Neirinck, L; Zhu, Z | 1 |
| Altiokka, G; Kircali, K | 1 |
| Lanchote, VL; Queiroz, RH; Zainaghi, IA | 1 |
| de la Torre, R; Farré, M; Joglar, J; Ortuño, J; Pacifici, R; Pichini, S; Segura, J; Segura, M | 1 |
| Brightwell, M; De Biasi, V; Zukowski, J | 1 |
| Bieling, P; Garson, C; Goldapple, K; Kennedy, S; Lau, M; Mayberg, H; Segal, Z | 1 |
| Eerkes, A; Naidong, W | 1 |
| Huande, L; Juan, H; Zhiling, Z | 1 |
| Berger, U; Jensen, E; Kallenborn, R; Samuelsen, PJ; Vasskog, T | 1 |
| Iga, J; Kinouchi, S; Morita, K; Motoki, I; Numata, S; Ohmori, T; Ohta, K; Rokutan, K; Sano, A; Song, H; Tanabe, H; Tayoshi, S; Ueno, S; Yamauchi, K | 1 |
| Alarfaj, N; Razeq, SA; Sultan, M | 1 |
| Danhof, M; Della Pasqua, O; Gomeni, R; Santen, G | 1 |
| Bereza, BG; Einarson, TR; Iskedjian, M; Le Melledo, JM; Walker, JH | 1 |
| Härtter, S; Hermes, B; Hiemke, C; Szegedi, A | 1 |
| Karnes, HT; Ramaiya, A | 1 |
| Artigas, F; Romero, L | 1 |
| Clement, EM; Franklin, M; Odontiadis, J | 1 |
| Ferretti, R; Gallinella, B; La Torre, F; Turchetto, L | 1 |
| Cha, IJ; Kim, KA; Kim, YH; Shin, JG; Shin, SG; Yoon, YR | 1 |
| Dominguez, N; López-Calull, C | 1 |
| Bugge, A; Kristoffersen, L; Lundanes, E; Slørdal, L | 1 |
| Gentilini, G; Lopez-Silva, S; Lucca, A; Soldarini, A | 1 |
| Fauler, G; Leis, HJ; Raspotnig, G; Windischhofer, W | 1 |
| Greibrokk, T; Kristoffersen, L; Lundanes, E; Molander, P; Thomassen, A | 1 |
2 review(s) available for paroxetine and Sensitivity and Specificity
| Article | Year |
|---|---|
Is
Topics: Aged; Aging; Blood Glucose; Brain; Case-Control Studies; Depression; Fluorodeoxyglucose F18; Humans; Paroxetine; Positron-Emission Tomography; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sleep Deprivation | 2017 |
Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Humans; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Venlafaxine Hydrochloride | 2017 |
3 trial(s) available for paroxetine and Sensitivity and Specificity
| Article | Year |
|---|---|
Clinical evaluation of the Daily Assessment of Symptoms-Anxiety (DAS-A): a new instrument to assess the onset of symptomatic improvement in generalized anxiety disorder.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Double-Blind Method; Female; Humans; Lorazepam; Male; Middle Aged; Paroxetine; Sensitivity and Specificity | 2009 |
Sensitivity of the Montgomery Asberg Depression Rating Scale to response and its consequences for the assessment of efficacy.
Topics: Antidepressive Agents, Second-Generation; Databases, Bibliographic; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Paroxetine; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Gene expression and association analysis of LIM (PDLIM5) in major depression.
Topics: Adaptor Proteins, Signal Transducing; Adult; Biomarkers; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Gene Expression; Gene Expression Profiling; Humans; Leukocytes; LIM Domain Proteins; Male; Paroxetine; Reproducibility of Results; Risk Assessment; Risk Factors; Sensitivity and Specificity; Statistics as Topic; Treatment Outcome | 2006 |
29 other study(ies) available for paroxetine and Sensitivity and Specificity
| Article | Year |
|---|---|
Benefit of slow titration of paroxetine to treat depression in the elderly.
Topics: Aged; Antidepressive Agents, Second-Generation; Computer Simulation; Cost-Benefit Analysis; Depressive Disorder, Major; Female; Humans; Italy; Male; Paroxetine; Patient Dropouts; Sensitivity and Specificity; Treatment Outcome | 2014 |
Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical
Topics: Antidepressive Agents, Second-Generation; Chemistry, Pharmaceutical; Chromatography, Liquid; Drug Contamination; Drug Industry; Molecular Structure; Neurotoxicity Syndromes; Paroxetine; Pharmaceutical Preparations; Pyridines; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2008 |
Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids.
Topics: Chromatography, High Pressure Liquid; Cyclohexanols; Duloxetine Hydrochloride; Fluoxetine; Humans; Limit of Detection; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Thiophenes; Venlafaxine Hydrochloride | 2009 |
A rapid LC-MS/MS method for quantitation of eszopiclone in human plasma: application to a human pharmacokinetic study.
Topics: Azabicyclo Compounds; Chromatography, Liquid; Drug Stability; Eszopiclone; Humans; Linear Models; Male; Paroxetine; Piperazines; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
Improved sample preparation for the quantitative analysis of paroxetine in human plasma by stable isotope dilution negative ion chemical ionisation gas chromatography-mass spectrometry.
Topics: Calibration; Gas Chromatography-Mass Spectrometry; Humans; Hydrogen-Ion Concentration; Isotopes; Paroxetine; Reference Standards; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity | 2002 |
High-performance liquid chromatography-mass spectrometry method for the determination of paroxetine in human plasma.
Topics: Chromatography, High Pressure Liquid; Humans; Mass Spectrometry; Paroxetine; Reference Standards; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity | 2002 |
Simple method of paroxetine determination using a single channel FIA with no in-line reaction process.
Topics: Calibration; Flow Injection Analysis; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2003 |
Determination of paroxetine in geriatric depression by high-performance liquid chromatography.
Topics: Age Factors; Aged; Analysis of Variance; Chromatography, High Pressure Liquid; Depression; Drug Interactions; Drug Monitoring; Female; Humans; Male; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity | 2003 |
Quantitative determination of paroxetine and its 4-hydroxy-3-methoxy metabolite in plasma by high-performance liquid chromatography/electrospray ion trap mass spectrometry: application to pharmacokinetic studies.
Topics: Administration, Oral; Adult; Calibration; Chromatography, High Pressure Liquid; Humans; Hydrolysis; Male; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2003 |
Chiral HPLC method for chiral purity determination of paroxetine drug substance.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Paroxetine; Sensitivity and Specificity; Stereoisomerism | 2003 |
Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.
Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Blood Glucose; Brain Mapping; Cerebral Cortex; Cognitive Behavioral Therapy; Depressive Disorder, Major; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Frontal Lobe; Humans; Limbic System; Male; Middle Aged; Nerve Net; Neural Pathways; Outcome and Process Assessment, Health Care; Paroxetine; Personality Inventory; Prefrontal Cortex; Sensitivity and Specificity; Tomography, Emission-Computed | 2004 |
Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the analysis of paroxetine in human plasma.
Topics: Chromatography, High Pressure Liquid; Humans; Paroxetine; Reference Standards; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization | 2004 |
Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography-electrospray ionization mass spectrometry (HPLC-MS/ESI).
Topics: Antidepressive Agents, Tricyclic; Chromatography, High Pressure Liquid; Citalopram; Cyclohexanols; Depression; Female; Fluoxetine; Humans; Male; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Venlafaxine Hydrochloride | 2005 |
Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.
Topics: Calibration; Chemical Fractionation; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Fluvoxamine; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sewage; Water Pollutants, Chemical | 2006 |
Spectrofluorimetric determination of paroxetine hydrochloride in its formulations and human plasma.
Topics: Chemistry, Pharmaceutical; Humans; Paroxetine; Plasma; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Fluorescence | 2006 |
Sensitivity of the individual items of the Hamilton depression rating scale to response and its consequences for the assessment of efficacy.
Topics: Depressive Disorder, Major; Double-Blind Method; Endpoint Determination; False Negative Reactions; Humans; Linear Models; Longitudinal Studies; Paroxetine; Placebos; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Agitation; Randomized Controlled Trials as Topic; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sleep Initiation and Maintenance Disorders; Suicide; Time Factors; Treatment Outcome | 2008 |
Evaluation of treatment response in depression studies using a Bayesian parametric cure rate model.
Topics: Antidepressive Agents; Bayes Theorem; Depressive Disorder; Endpoint Determination; Humans; Kaplan-Meier Estimate; Linear Models; Paroxetine; Psychiatric Status Rating Scales; Psychometrics; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Time Factors; Treatment Outcome | 2008 |
Cost-effectiveness of escitalopram for generalized anxiety disorder in Canada.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Canada; Chronic Disease; Citalopram; Confidence Intervals; Cost of Illness; Cost Savings; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Monte Carlo Method; Paroxetine; Primary Health Care; Sensitivity and Specificity; Severity of Illness Index | 2008 |
Automated determination of paroxetine and its main metabolite by column switching and on-line high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Humans; Imipramine; Mixed Function Oxygenases; Paroxetine; Piperidines; Sensitivity and Specificity | 1994 |
Simultaneous measurement of serotonin and paroxetine in rat brain microdialysate by a single-pump column-switching technique.
Topics: Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Male; Microdialysis; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Serotonin; Temperature | 1997 |
Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
Topics: Animals; Autoradiography; Autoreceptors; Citalopram; Dendrites; Male; Microdialysis; Paroxetine; Piperazines; Prosencephalon; Pyridines; Raphe Nuclei; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Serotonin; Serotonin Antagonists; Tritium | 1997 |
Simultaneous measurement of venlafaxine and its major metabolite, oxydesmethylvenlafaxine, in human plasma by high-performance liquid chromatography with coulometric detection and utilisation of solid-phase extraction.
Topics: Administration, Oral; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Humans; Paroxetine; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Venlafaxine Hydrochloride | 1998 |
Validated chiral high-performance liquid chromatographic method for the determination of trans-(-)-paroxetine and its enantiomer in bulk and pharmaceutical formulations.
Topics: Chromatography, High Pressure Liquid; Evaluation Studies as Topic; Paroxetine; Pharmaceutical Preparations; Reproducibility of Results; Sensitivity and Specificity; Stereoisomerism | 1998 |
Rapid simple high-performance liquid chromatographic determination of paroxetine in human plasma.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 1998 |
Determination of paroxetine in plasma by high-performance liquid chromatography for bioequivalence studies.
Topics: Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Humans; Paroxetine; Reference Standards; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrometry, Fluorescence; Therapeutic Equivalency | 1999 |
Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection.
Topics: Acetonitriles; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Humans; Hydrogen-Ion Concentration; Paroxetine; Quality Control; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet | 1999 |
Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluorometry; Fluoxetine; Fluvoxamine; Humans; Linear Models; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline | 2000 |
Stable isotope dilution negative ion chemical ionization gas chromatography-mass spectrometry for the quantitative analysis of paroxetine in human plasma.
Topics: Calibration; Deuterium; Gas Chromatography-Mass Spectrometry; Humans; Metabolic Clearance Rate; Molecular Structure; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Solvents | 2001 |
Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma by temperature-programmed packed capillary liquid chromatography with on-column focusing of large injection volumes.
Topics: Chromatography, Liquid; Citalopram; Fluoxetine; Humans; Paroxetine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2002 |